197 related articles for article (PubMed ID: 12446580)
1. Ovarian dependence for pituitary tumorigenesis in D2 dopamine receptor-deficient mice.
Hentges ST; Low MJ
Endocrinology; 2002 Dec; 143(12):4536-43. PubMed ID: 12446580
[TBL] [Abstract][Full Text] [Related]
2. Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice.
Asa SL; Kelly MA; Grandy DK; Low MJ
Endocrinology; 1999 Nov; 140(11):5348-55. PubMed ID: 10537166
[TBL] [Abstract][Full Text] [Related]
3. Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms.
Schuff KG; Hentges ST; Kelly MA; Binart N; Kelly PA; Iuvone PM; Asa SL; Low MJ
J Clin Invest; 2002 Oct; 110(7):973-81. PubMed ID: 12370275
[TBL] [Abstract][Full Text] [Related]
4. PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes.
Cristina C; Díaz-Torga GS; Goya RG; Kakar SS; Perez-Millán MI; Passos VQ; Giannella-Neto D; Bronstein MD; Becu-Villalobos D
Mol Cancer; 2007 Jan; 6():4. PubMed ID: 17222350
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of antivascular endothelial growth factor strategies in experimental dopamine-resistant prolactinomas.
Luque GM; Perez-Millán MI; Ornstein AM; Cristina C; Becu-Villalobos D
J Pharmacol Exp Ther; 2011 Jun; 337(3):766-74. PubMed ID: 21406548
[TBL] [Abstract][Full Text] [Related]
6. Leukemia inhibitory factor regulates prolactin secretion in prolactinoma and lactotroph cells.
Ben-Shlomo A; Miklovsky I; Ren SG; Yong WH; Heaney AP; Culler MD; Melmed S
J Clin Endocrinol Metab; 2003 Feb; 88(2):858-63. PubMed ID: 12574225
[TBL] [Abstract][Full Text] [Related]
7. Fetal Alcohol Exposure Reduces Dopamine Receptor D2 and Increases Pituitary Weight and Prolactin Production via Epigenetic Mechanisms.
Gangisetty O; Wynne O; Jabbar S; Nasello C; Sarkar DK
PLoS One; 2015; 10(10):e0140699. PubMed ID: 26509893
[TBL] [Abstract][Full Text] [Related]
8. Interactions between transplanted pituitary tumor and gonads in nude mice.
Mori H; Maeda T; Yamashita H; Makino S; Hayashi Y
Pathol Res Pract; 1988 Sep; 183(5):642-4. PubMed ID: 3237552
[TBL] [Abstract][Full Text] [Related]
9. mPRs represent a novel target for PRL inhibition in experimental prolactinomas.
Camilletti MA; Abeledo-Machado A; Perez PA; Faraoni EY; De Fino F; Rulli SB; Ferraris J; Pisera D; Gutierrez S; Thomas P; Díaz-Torga G
Endocr Relat Cancer; 2019 May; 26(5):497-510. PubMed ID: 30856609
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic D2 receptor knockout mouse: an animal model of prolactinoma.
Cristina C; García-Tornadú I; Díaz-Torga G; Rubinstein M; Low MJ; Becú-Villalobos D
Front Horm Res; 2006; 35():50-63. PubMed ID: 16809922
[TBL] [Abstract][Full Text] [Related]
11. Pituitary prolactin-secreting tumor formation: recent developments.
Xu RK; Wu XM; Di AK; Xu JN; Pang CS; Pang SF
Biol Signals Recept; 2000; 9(1):1-20. PubMed ID: 10686432
[TBL] [Abstract][Full Text] [Related]
12. Active and total transforming growth factor-β1 are differentially regulated by dopamine and estradiol in the pituitary.
Recouvreux MV; Guida MC; Rifkin DB; Becu-Villalobos D; Díaz-Torga G
Endocrinology; 2011 Jul; 152(7):2722-30. PubMed ID: 21521749
[TBL] [Abstract][Full Text] [Related]
13. Targeted overexpression of luteinizing hormone causes ovary-dependent functional adenomas restricted to cells of the Pit-1 lineage.
Mohammad HP; Abbud RA; Parlow AF; Lewin JS; Nilson JH
Endocrinology; 2003 Oct; 144(10):4626-36. PubMed ID: 12960102
[TBL] [Abstract][Full Text] [Related]
14. Increased pituitary vascular endothelial growth factor-a in dopaminergic D2 receptor knockout female mice.
Cristina C; Díaz-Torga G; Baldi A; Góngora A; Rubinstein M; Low MJ; Becú-Villalobos D
Endocrinology; 2005 Jul; 146(7):2952-62. PubMed ID: 15817666
[TBL] [Abstract][Full Text] [Related]
15. New insights into the endocrine and metabolic roles of dopamine D2 receptors gained from the Drd2 mouse.
Garcia-Tornadú I; Perez-Millan MI; Recouvreux V; Ramirez MC; Luque G; Risso GS; Ornstein AM; Cristina C; Diaz-Torga G; Becu-Villalobos D
Neuroendocrinology; 2010; 92(4):207-14. PubMed ID: 20975260
[TBL] [Abstract][Full Text] [Related]
16. Each individual isoform of the dopamine D2 receptor protects from lactotroph hyperplasia.
Radl D; De Mei C; Chen E; Lee H; Borrelli E
Mol Endocrinol; 2013 Jun; 27(6):953-65. PubMed ID: 23608643
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor-2 in hyperplastic pituitaries of D2R knockout female mice.
Cristina C; Díaz-Torga G; Góngora A; Guida MC; Perez-Millán MI; Baldi A; Becu-Villalobos D
Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1341-51. PubMed ID: 17848635
[TBL] [Abstract][Full Text] [Related]
18. Effects of 17 beta-estradiol and medroxyprogesterone acetate upon MtTW15 mammosomatotropic pituitary tumor growth and hormone production in male and female rats.
Winneker RC; Parsons JA
Cancer Res; 1981 May; 41(5):1772-7. PubMed ID: 7214344
[TBL] [Abstract][Full Text] [Related]
19. Cell-specific induction of c-fos expression in the pituitary gland by estrogen.
Allen DL; Mitchner NA; Uveges TE; Nephew KP; Khan S; Ben-Jonathan N
Endocrinology; 1997 May; 138(5):2128-35. PubMed ID: 9112413
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting MAPK14 showed anti-prolactinoma effect.
Ding QY; Zhang Y; Ma L; Chen YG; Wu JH; Zhang HF; Wang X
BMC Endocr Disord; 2020 Sep; 20(1):138. PubMed ID: 32894113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
